Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-336
Closed -$2.22K 451
2025
Q4
$2.22K Hold
336
﹤0.01% 442
2025
Q3
$4.34K Hold
336
﹤0.01% 392
2025
Q2
$6.04K Hold
336
﹤0.01% 392
2025
Q1
$7.26K Hold
336
﹤0.01% 371
2024
Q4
$6.32K Hold
336
﹤0.01% 358
2024
Q3
$12.4K Hold
336
﹤0.01% 348
2024
Q2
$8.21K Hold
336
﹤0.01% 337
2024
Q1
$21.5K Sell
336
-8
-2% -$605 ﹤0.01% 339
2023
Q4
$42.6K Hold
344
﹤0.01% 330
2023
Q3
$45.7K Hold
344
0.01% 313
2023
Q2
$63.2K Hold
344
0.01% 337
2023
Q1
$57.9K Buy
344
+8
+2% +$1.68K 0.01% 330
2022
Q4
$72.5K Sell
336
-4
-1% -$1.51K 0.01% 327
2022
Q3
$132K Buy
340
+9
+3% +$5.1K 0.02% 301
2022
Q2
$139K Hold
331
0.03% 220
2022
Q1
$197K Buy
331
+102
+45% +$75.8K 0.02% 310
2021
Q4
$254K Sell
229
-14
-6% -$30.4K 0.03% 278
2021
Q3
$933K Buy
243
+18
+8% +$56.8K 0.12% 148
2021
Q2
$648K Hold
225
0.14% 122
2021
Q1
$449K Hold
225
0.11% 141
2020
Q4
$215K Hold
225
0.06% 191
2020
Q3
$180K Hold
225
0.06% 182
2020
Q2
$214K Buy
+225
New +$225K 0.07% 177

Other funds holding PAVM

XML Financial's PAVM Position: Q1 2026 in Review

XML Financial sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 336 shares — an estimated $2.22K sold.

XML Financial first reported a position in PAVM in Q2 2020 and held it in 23 quarters. The position peaked at $933K in Q3 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • XML Financial reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
  • XML Financial sold 336 PAVmed shares in Q1 2026, an estimated $2.22K.
  • XML Financial first reported a position in PAVmed in Q2 2020 and held it in 23 quarters.
  • XML Financial's PAVmed position peaked at $933K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on XML Financial's 13F filing for Q1 2026, filed 16 Apr 2026.